Asian Journal of Complementary and Alternative Medicine

Development and effectiveness validation of the ICF-COVID combination scale

Jue Li, M.M¹, Lin Chen, M.D¹, Wei Ren, M.M¹, Min Wen, MBBS², Shouguo Liu, M.D³, Hai Li, M.D¹, Jianan Li , M.D^3# and Wenzhi Cai, M.D^1#

¹Department of nursing, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, People’s Republic of China

²Department of nursing, The Third People’s Hospital of Shenzhen, Guangdong, People’s Republic of China

³Department of Rehabilitation Medicine, The First Affiliated Hospital With Nanjing Medical University, Jiangsu, Nanjing , People’s Republic of China

Abstract

Objective: To develop an ICF-COVID scale and evaluate its reliability and validity. By establishing such a scale, we hope to provide clinical advices for the rehabilitation of suspected patients with new covavirus pneumonia.

Design：Firstly, literature review and expert group-discussion were applied to determine the initial items of the ICF-COVID scale. Secondly, the ICF-COVID scale was applied in 155 suspected patients with new coronary pneumonia by online survey. Finally, the reliability and validity of the scale were evaluated.

Setting: A face-to-face offline research but in an electronic survey manner.

Perticipants: 155 suspected patients with new coronary pneumonia from ten hospitals.

Interventions: Not applicable.

Main Outcome Measures: Cronbach α coefficient, Spearman-Brown half-reliability coefficient, KMO value, S-CVI value and I-CVI value.

Results: The ICF-COVID scale contains five items. The Cronbach α coefficient of the scale was 0.861. Spearman-Brown half- reliability coefficient was 0.814. KMO value was 0.854. S-CVI value was 0.813, and I-CVI value was between 0.846 and 1.000.

Conclusion: The ICF-COVID scale had a good reliability and validity. It can evaluate the health and function status of patients with new coronary pneumonia.

Keywords:

new coronary pneumonia; ICF; ICF generic set; functional evaluation; reliability; validity